EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 62 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,930,343 | -8.2% | 3,370,506 | 0.0% | 0.53% | -4.3% |
| Q2 2023 | $29,323,402 | +195.9% | 3,370,506 | 0.0% | 0.55% | +147.3% |
| Q1 2023 | $9,909,288 | -16.0% | 3,370,506 | 0.0% | 0.22% | -6.3% |
| Q4 2022 | $11,796,771 | -55.8% | 3,370,506 | 0.0% | 0.24% | -58.0% |
| Q3 2022 | $26,660,000 | +0.5% | 3,370,506 | 0.0% | 0.57% | -19.5% |
| Q2 2022 | $26,526,000 | -35.2% | 3,370,506 | 0.0% | 0.71% | -20.9% |
| Q1 2022 | $40,952,000 | -0.7% | 3,370,506 | 0.0% | 0.89% | +23.0% |
| Q4 2021 | $41,255,000 | +79.1% | 3,370,506 | +52.5% | 0.73% | +127.9% |
| Q3 2021 | $23,033,000 | +105.0% | 2,210,506 | +76.8% | 0.32% | +77.2% |
| Q2 2021 | $11,238,000 | -11.5% | 1,250,000 | 0.0% | 0.18% | -6.2% |
| Q1 2021 | $12,700,000 | – | 1,250,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $14,668,224 | 8.18% |
| Caligan Partners LP | 435,298 | $1,523,543 | 1.27% |
| ACUTA CAPITAL PARTNERS, LLC | 303,396 | $1,061,886 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,347,897 | $11,717,640 | 0.49% |
| Samsara BioCapital, LLC | 480,000 | $1,680,000 | 0.36% |
| RA Capital Management | 3,370,506 | $11,796,771 | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 201,810 | $706 | 0.11% |
| Legato Capital Management LLC | 76,130 | $266,455 | 0.05% |
| BARD ASSOCIATES INC | 30,674 | $107,359 | 0.05% |
| LEVIN CAPITAL STRATEGIES, L.P. | 79,000 | $276,500 | 0.04% |